Schedule 13D ownership disclosure

TRANSCODE THERAPEUTICS INC

Common Stock · CUSIP: 89357L501

Event date: 2025-10-08

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • CK Life Sciences Int'l., (Holdings) Inc.Reported CIK 0001297567

    Shares: 83,285.00 · Class: 9.1%

  • DEFJ, LLC

    Shares: 83,285.00 · Class: 9.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-100081
Form type
SCHEDULE 13D
Filer
CK Life Sciences Intl (Holdings) Inc
CIK
CIK 1297567
Filed
Oct 16, 2025
Reporting period
Oct 08, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub